BRPI0211439B1 - Composition of synergistic charge and pharmaceutical tablet - Google Patents
Composition of synergistic charge and pharmaceutical tablet Download PDFInfo
- Publication number
- BRPI0211439B1 BRPI0211439B1 BRPI0211439-9A BR0211439A BRPI0211439B1 BR PI0211439 B1 BRPI0211439 B1 BR PI0211439B1 BR 0211439 A BR0211439 A BR 0211439A BR PI0211439 B1 BRPI0211439 B1 BR PI0211439B1
- Authority
- BR
- Brazil
- Prior art keywords
- tablet
- composition
- synergistic
- copolymer
- pvp
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 27
- 230000002195 synergetic effect Effects 0.000 title claims abstract description 13
- 229920001577 copolymer Polymers 0.000 claims abstract description 19
- 239000000945 filler Substances 0.000 claims abstract description 12
- 239000003814 drug Substances 0.000 claims description 15
- GUBGYTABKSRVRQ-UHFFFAOYSA-N 2-(hydroxymethyl)-6-[4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxane-3,4,5-triol Chemical compound OCC1OC(OC2C(O)C(O)C(O)OC2CO)C(O)C(O)C1O GUBGYTABKSRVRQ-UHFFFAOYSA-N 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 229920000168 Microcrystalline cellulose Polymers 0.000 abstract description 14
- 235000019813 microcrystalline cellulose Nutrition 0.000 abstract description 14
- 239000008108 microcrystalline cellulose Substances 0.000 abstract description 10
- 229940016286 microcrystalline cellulose Drugs 0.000 abstract description 10
- 238000007906 compression Methods 0.000 abstract description 5
- 230000006835 compression Effects 0.000 abstract description 5
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 6
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 4
- 229960001138 acetylsalicylic acid Drugs 0.000 description 4
- HSUGRBWQSSZJOP-RTWAWAEBSA-N diltiazem Chemical compound C1=CC(OC)=CC=C1[C@H]1[C@@H](OC(C)=O)C(=O)N(CCN(C)C)C2=CC=CC=C2S1 HSUGRBWQSSZJOP-RTWAWAEBSA-N 0.000 description 3
- 229960004166 diltiazem Drugs 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 description 3
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 description 3
- 238000009472 formulation Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229960005489 paracetamol Drugs 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
- 229940038472 dicalcium phosphate Drugs 0.000 description 1
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
- FYUWIEKAVLOHSE-UHFFFAOYSA-N ethenyl acetate;1-ethenylpyrrolidin-2-one Chemical compound CC(=O)OC=C.C=CN1CCCC1=O FYUWIEKAVLOHSE-UHFFFAOYSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229940126601 medicinal product Drugs 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000007916 tablet composition Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Seeds, Soups, And Other Foods (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/915.057 | 2001-07-25 | ||
| US09/915,057 US6524617B1 (en) | 2001-07-25 | 2001-07-25 | Synergistic filler composition |
| PCT/US2002/014586 WO2003011253A1 (en) | 2001-07-25 | 2002-05-10 | Synergistic filler composition |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| BR0211439A BR0211439A (pt) | 2004-07-20 |
| BRPI0211439B1 true BRPI0211439B1 (pt) | 2017-09-19 |
| BRPI0211439B8 BRPI0211439B8 (enExample) | 2021-05-25 |
Family
ID=25435143
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0211439-9A BRPI0211439B1 (pt) | 2001-07-25 | 2002-05-10 | Composition of synergistic charge and pharmaceutical tablet |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6524617B1 (enExample) |
| EP (1) | EP1416918B1 (enExample) |
| JP (1) | JP4805537B2 (enExample) |
| CN (1) | CN1268320C (enExample) |
| AT (1) | ATE327738T1 (enExample) |
| BR (1) | BRPI0211439B1 (enExample) |
| CA (1) | CA2454449C (enExample) |
| DE (1) | DE60211916T2 (enExample) |
| ES (1) | ES2266502T3 (enExample) |
| MX (1) | MXPA04000666A (enExample) |
| RU (1) | RU2304981C2 (enExample) |
| WO (1) | WO2003011253A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6620900B2 (en) * | 2002-02-07 | 2003-09-16 | Isp Investments Inc. | Proliferous copolymer of vinyl pyrrolidone and vinyl acetate |
| JP4776233B2 (ja) * | 2002-11-12 | 2011-09-21 | エラン ファーマ インターナショナル，リミティド | 摩損しにくくかつプルランを含む速崩壊性固形製剤 |
| US7704528B2 (en) * | 2003-05-05 | 2010-04-27 | Isp Investments Inc. | Binder composition and method for processing poorly compressible drugs into tablets of predetermined hardness and friability |
| US20070036859A1 (en) * | 2005-08-11 | 2007-02-15 | Perry Ronald L | Sustained release antihistamine and decongestant composition |
| US8168219B2 (en) * | 2005-11-30 | 2012-05-01 | Isp Investments Inc. | Synergistic binder composition, method for making same, and tablets of an active and said binder having advantageous hardness and friability |
| ES2738659T3 (es) * | 2013-03-12 | 2020-01-24 | Hercules Llc | Composición de polímero revestida con sílice co-procesada |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU183408B (en) * | 1981-04-28 | 1984-05-28 | Chinoin Gyogyszer Es Vegyeszet | Process for producing oral ratard pharmaceutical compositions |
| US5326570A (en) * | 1991-07-23 | 1994-07-05 | Pharmavene, Inc. | Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine |
| US6221399B1 (en) * | 1995-08-17 | 2001-04-24 | Csir | Method of making controlled release particles of complexed polymers |
| AT413647B (de) * | 1998-11-26 | 2006-04-15 | Sandoz Ag | Verwendung eines copolymerisats aus 1-vinyl-2-pyrrolidon und vinylacetat zur herstellung von cefuroximaxetil-hältigen tabletten |
-
2001
- 2001-07-25 US US09/915,057 patent/US6524617B1/en not_active Expired - Lifetime
-
2002
- 2002-05-10 MX MXPA04000666A patent/MXPA04000666A/es active IP Right Grant
- 2002-05-10 EP EP02734286A patent/EP1416918B1/en not_active Expired - Lifetime
- 2002-05-10 ES ES02734286T patent/ES2266502T3/es not_active Expired - Lifetime
- 2002-05-10 WO PCT/US2002/014586 patent/WO2003011253A1/en not_active Ceased
- 2002-05-10 JP JP2003516485A patent/JP4805537B2/ja not_active Expired - Lifetime
- 2002-05-10 AT AT02734286T patent/ATE327738T1/de not_active IP Right Cessation
- 2002-05-10 DE DE60211916T patent/DE60211916T2/de not_active Expired - Lifetime
- 2002-05-10 RU RU2004105268/15A patent/RU2304981C2/ru active
- 2002-05-10 CN CNB028185161A patent/CN1268320C/zh not_active Expired - Lifetime
- 2002-05-10 CA CA2454449A patent/CA2454449C/en not_active Expired - Lifetime
- 2002-05-10 BR BRPI0211439-9A patent/BRPI0211439B1/pt not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1416918A4 (en) | 2004-08-18 |
| CN1556695A (zh) | 2004-12-22 |
| CA2454449C (en) | 2010-10-26 |
| EP1416918A1 (en) | 2004-05-12 |
| RU2304981C2 (ru) | 2007-08-27 |
| US20030031708A1 (en) | 2003-02-13 |
| MXPA04000666A (es) | 2004-04-05 |
| ES2266502T3 (es) | 2007-03-01 |
| JP2005501049A (ja) | 2005-01-13 |
| DE60211916D1 (de) | 2006-07-06 |
| WO2003011253A1 (en) | 2003-02-13 |
| BRPI0211439B8 (enExample) | 2021-05-25 |
| CN1268320C (zh) | 2006-08-09 |
| ATE327738T1 (de) | 2006-06-15 |
| BR0211439A (pt) | 2004-07-20 |
| EP1416918B1 (en) | 2006-05-31 |
| US6524617B1 (en) | 2003-02-25 |
| RU2004105268A (ru) | 2005-03-10 |
| CA2454449A1 (en) | 2003-02-13 |
| DE60211916T2 (de) | 2007-01-04 |
| JP4805537B2 (ja) | 2011-11-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6190696B1 (en) | Stabilized thyroxine medications | |
| Doelker | Comparative compaction properties of various microcrystalline cellulose types and generic products | |
| Varshosaz et al. | Use of hydrophilic natural gums in formulation of sustained-release matrix tablets of tramadol hydrochloride | |
| US5958453A (en) | Solid pharmaceutical preparation with improved buccal disintegrability and/or dissolubility | |
| DE69837945T2 (de) | Tablette, umfassend ein phosphatbindendes Polymer | |
| EP0689429B1 (en) | Cross-linked amylose as a binder/disintegrant in tablets | |
| EP1509205B1 (de) | Pharmazeutische zusammensetzung mit verzögerter wirkstofffreisetzung und verfahren zu deren zubereitung | |
| US3632778A (en) | Tablets containing l-dopa | |
| CN111840239B (zh) | 一种普瑞巴林缓释制剂 | |
| US20060088594A1 (en) | Highly compressible controlled delivery compositions of metformin | |
| BRPI0211439B1 (pt) | Composition of synergistic charge and pharmaceutical tablet | |
| EP1755559A1 (en) | Bioavailable solid dosage forms of metaxalone | |
| EP1322294B1 (en) | Stabilization of solid thyroid drug formulations | |
| Knapczyk | Antimycotic buccal and vaginal tablets with chitosan | |
| JP3884056B1 (ja) | 口腔内速崩錠の製造方法 | |
| CN1039673C (zh) | 阿糖胞苷十八烷基磷酸盐硬胶囊 | |
| CA2616845A1 (en) | Modified release tablet formulations with enhanced mechanical properties | |
| WO1999043302A1 (en) | Stabilizing composition for pharmaceutical dosage forms | |
| WO2004037263A1 (en) | Pharmaceutical compositions of ganciclovir | |
| CZ119498A3 (cs) | Kaptoprilové tablety | |
| Kumar et al. | Formulation and evaluation of matrix tablets of acarbose. | |
| KR101920307B1 (ko) | 고정용량의 실로스타졸 서방출 및 스타틴 일반방출 미니정제를 포함하는 1일 1회 경구복용 복합 캡슐제 및 이의 제조방법 | |
| Narla et al. | Formulation and evaluation of sustained release metoprolol succinate matrix tablets by direct compression process by using Kollidon SR | |
| JP2676305B2 (ja) | シタラビンオクホスファート硬カプセル剤 | |
| Chakraborty et al. | Development of extended release divalproex sodium tablets containing hypdrophobic and hydrophilic matrix |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] | ||
| B12B | Appeal against refusal [chapter 12.2 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B15K | Others concerning applications: alteration of classification |
Ipc: A61K 9/14 (2006.01), A61K 9/16 (2006.01), A61K 9/2 |
|
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] | ||
| B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 10/05/2002 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |
|
| B25D | Requested change of name of applicant approved | ||
| B25G | Requested change of headquarter approved | ||
| B25L | Entry of change of name and/or headquarter and transfer of application, patent and certificate of addition of invention: publication cancelled |
Free format text: ANULADA A PUBLICACAO CODIGO 25.7 NA RPI NO 2649 DE 13/10/2021 POR TER SIDO INDEVIDA. |
|
| B25L | Entry of change of name and/or headquarter and transfer of application, patent and certificate of addition of invention: publication cancelled |
Free format text: ANULADA A PUBLICACAO CODIGO 25.4 NA RPI NO 2648 DE 05/10/2021 POR TER SIDO INDEVIDA. |
|
| B25D | Requested change of name of applicant approved | ||
| B25G | Requested change of headquarter approved | ||
| B21A | Patent or certificate of addition expired [chapter 21.1 patent gazette] |
Free format text: PATENTE EXTINTA EM 10/05/2022 |